Medtronic Future Growth

Future criteria checks 1/6

Medtronic is forecast to grow earnings and revenue by 10% and 4.3% per annum respectively. EPS is expected to grow by 11% per annum. Return on equity is forecast to be 14.1% in 3 years.

Key information

10.0%

Earnings growth rate

11.0%

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth rate4.3%
Future return on equity14.1%
Analyst coverage

Good

Last updated22 Mar 2024

Recent future growth updates

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Recent updates

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11
Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29
Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12
Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: The Tide Is Turning

Aug 24

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Aug 21
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: Dark Clouds Are Clearing - Outperformance Ahead

Aug 14

Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Aug 11
Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth

Jul 15

Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Jul 09
Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Is Medtronic (NYSE:MDT) A Risky Investment?

Jun 21
Is Medtronic (NYSE:MDT) A Risky Investment?

Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter

Jun 21

Is Medtronic's Dividend In A Good Place?

Jun 14

Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Jun 03
Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Medtronic: Solid Q4 Earnings, Don't Fret About Guidance

May 26

Investors Met With Slowing Returns on Capital At Medtronic (NYSE:MDT)

May 04
Investors Met With Slowing Returns on Capital At Medtronic (NYSE:MDT)

Does This Valuation Of Medtronic plc (NYSE:MDT) Imply Investors Are Overpaying?

Mar 10
Does This Valuation Of Medtronic plc (NYSE:MDT) Imply Investors Are Overpaying?

Where Will Medtronic Stock Be In 4 Years?

Feb 17

Medtronic: A Trend Change May Be Underway Ahead Of Earnings

Feb 06

Medtronic recalls ~23K Mahurkar hemodialysis catheters

Jan 30

These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

Jan 24
These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

Medtronic: Destruction Is Nearly Over

Jan 06

Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Dec 28
Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Earnings and Revenue Growth Forecasts

NYSE:MDT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
4/30/202635,2675,4816,7248,39724
4/30/202533,5825,1135,9577,80131
4/30/202432,2214,4225,7037,31430
1/26/202432,3204,2014,9316,470N/A
10/27/202331,9584,1024,0455,570N/A
7/28/202331,5583,6204,4445,831N/A
4/28/202331,2273,7584,5806,039N/A
1/27/202330,7714,0644,1665,636N/A
10/28/202230,8064,3214,8226,290N/A
7/29/202231,0705,2055,7217,137N/A
4/29/202231,6865,0395,9787,346N/A
1/28/202231,7854,9145,6787,034N/A
10/29/202131,7984,7045,7737,162N/A
7/30/202131,5973,8825,8557,254N/A
4/30/202130,1173,6064,8856,240N/A
1/29/202127,9262,8924,6315,945N/A
10/30/202027,8683,5374,7525,996N/A
7/31/202027,9274,4124,7566,002N/A
4/24/202028,9134,7896,0217,234N/A
1/24/202031,0625,4086,6597,871N/A
10/25/201930,8914,7626,2987,519N/A
7/26/201930,6664,4205,6716,815N/A
4/26/201930,5574,6315,8737,007N/A
1/25/201930,5554,8264,8675,958N/A
10/26/201830,3782,1684,8645,905N/A
7/27/201829,9473,1634,5685,649N/A
4/27/201829,9533,1043,6164,684N/A
1/26/201829,7252,8594,3135,419N/A
10/27/201729,6395,069N/A5,502N/A
7/28/201729,9344,115N/A6,067N/A
4/28/201729,7104,028N/A6,880N/A
1/27/201729,3613,968N/A6,433N/A
10/28/201629,0124,242N/A6,145N/A
7/29/201628,7253,647N/A5,952N/A
4/29/201628,8333,538N/A5,218N/A
1/29/201628,4352,434N/A5,804N/A
10/30/201525,8192,316N/A5,774N/A
7/31/201523,1272,624N/A5,408N/A
4/24/201520,2612,675N/A4,902N/A
1/23/201517,4103,124N/A4,318N/A
10/24/201417,2552,909N/A4,163N/A
7/25/201417,0832,983N/A4,286N/A
4/25/201416,8933,065N/A4,959N/A
1/24/201416,8793,586N/A4,901N/A
10/25/201316,7433,812N/A4,735N/A
7/26/201316,6443,556N/A4,593N/A
4/26/201316,5693,467N/A4,942N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MDT's forecast earnings growth (10% per year) is above the savings rate (2.3%).

Earnings vs Market: MDT's earnings (10% per year) are forecast to grow slower than the US market (13.4% per year).

High Growth Earnings: MDT's earnings are forecast to grow, but not significantly.

Revenue vs Market: MDT's revenue (4.3% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: MDT's revenue (4.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MDT's Return on Equity is forecast to be low in 3 years time (14.1%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.